Our research explores relationships between inflammation, cognition and mental health in different settings. Published findings help shape new questions and guide subsequent studies.
A research agenda exploring relationships between systemic inflammation, brain changes, and cognitive and psychiatric outcomes. It brings together research questions across clinical settings, with methods and participation requirements defined for each study.
Studies of cognitive changes after COVID-19 and their associations with inflammatory profiles and neuroimaging findings. Results are presented in the team’s publications.
Read the published study ↗A study in cohorts from Brazil and Argentina assessed the performance of plasma biomarkers associated with Alzheimer’s disease, considering clinical characteristics and genetic diversity.
Read the published study ↗Research into relationships between leukocyte telomeres, cognitive decline, APOE genotype and cardiovascular risk factors.
Read the published study ↗A systematic review of the literature on the effects of antipsychotics on the gastrointestinal microbiota, linking drug treatment with research into the gut-brain axis.
Read the published study ↗An investigation of associations between variants in circadian cycle genes and ADHD, bringing together molecular genetics and neurodevelopment.
Read the published study ↗We investigate associations between inflammatory processes, cognitive measures, biomarkers and neuroimaging. Each study’s design determines what its results can establish about mechanisms and causal relationships.
Results are presented in line with the supporting evidence; preliminary findings are not communicated as definitive conclusions.
The ICONEUS One fUSI platform was acquired with funding from Finep. The SIMOA SR-X, which is being set up, was acquired with support from Fapemig.
Contact the team to discuss academic and industry collaborations, joint studies and research services.
